Psilocybin molecule:

Image from PubChem

Psilocybin Clinical Trials


A Double-Blind Trial of Psilocybin-Assisted Treatment of Alcohol Dependence


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT02061293

Organisation Name: NYU Langone Health

Overal Status: Active, not recruiting

Start Date: June 2014

Last Update: April 3, 2020

Lead Sponsor: NYU Langone Health

Brief Summary: Several lines of evidence suggest that classic hallucinogens such as psilocybin can facilitate behavior change in addictions such as alcohol dependence. The proposed investigation is a multi-site, double-blind active-controlled trial (n = 180, 90 per group) contrasting the acute and persisting effects of psilocybin to those of diphenhydramine in the context of outpatient alcoholism treatment.

Conditions:
  • Alcohol Dependence


Total execution time in seconds: 0.19004797935486